Find Isoflurane manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 26675-46-7, Forane, 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane, Forene, Aerrane
Molecular Formula
C3H2ClF5O
Molecular Weight
184.49  g/mol
InChI Key
PIWKPBJCKXDKJR-UHFFFAOYSA-N
FDA UNII
CYS9AKD70P

Isoflurane
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Isoflurane is a General Anesthetic. The physiologic effect of isoflurane is by means of General Anesthesia.
1 2D Structure

Isoflurane

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
2.1.2 InChI
InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H
2.1.3 InChI Key
PIWKPBJCKXDKJR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(C(F)(F)F)(OC(F)F)Cl
2.2 Other Identifiers
2.2.1 UNII
CYS9AKD70P
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 26675-46-7

2. Forane

3. 1-chloro-2,2,2-trifluoroethyl Difluoromethyl Ether

4. 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane

5. Forene

6. Aerrane

7. Isoflurano

8. Compound 469

9. Isoflo

10. Isofluranum

11. Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-

12. R-e 235dal

13. Terrell

14. Ether, 1-chloro-2,2,2-trifluoroethyl Difluoromethyl

15. Hsdb 8057

16. Cys9akd70p

17. Compound-469

18. Chebi:6015

19. 2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane

20. Isofluranum [inn-latin]

21. Ncgc00181037-01

22. Aerrane (veterinary)

23. Dsstox_cid_752

24. Dsstox_rid_75769

25. Dsstox_gsid_20752

26. Isoba; Isofor; Isoforine; Isorrane; R-e 235da1

27. Isoflurano [inn-spanish]

28. Difluoromethyl 1-chloro-2,2,2-trifluoroethyl Ether (isoflurane)

29. Cas-26675-46-7

30. Forane (tn)

31. Ccris 3043

32. Isoflurane [anaesthetics, Volatile]

33. Einecs 247-897-7

34. Unii-cys9akd70p

35. Mfcd00066609

36. Brn 1852087

37. (+/-)-isoflurane

38. Isoflurane [usan:usp:inn:ban:jan]

39. Terrellhsdb 8057

40. Compd 469

41. Isoflurane, Aldrichcpr

42. Isoflurane [mi]

43. Isoflurane [inn]

44. Isoflurane [jan]

45. Isoflurane [usan]

46. Isoflurane [vandf]

47. Isoflurane [mart.]

48. Schembl1532

49. Chembl1256

50. Isoflurane [usp-rs]

51. Isoflurane [who-dd]

52. Difluoromethyl 1-chloro-2,2,2-trifluoroethyl Ether

53. Gtpl2505

54. Hsdb8057

55. Isoflurane (jp17/usp/inn)

56. Isoflurane [green Book]

57. Dtxsid3020752

58. Isoflurane [orange Book]

59. Hsdb-8057

60. Isoflurane [ep Monograph]

61. Bdbm217353

62. Isoflurane [usp Monograph]

63. Amy33546

64. Tox21_112685

65. Tox21_200831

66. Bbl100111

67. S6917

68. Stl454337

69. Akos006228574

70. Db00753

71. Ks-5166

72. Pb47772

73. Ncgc00181037-02

74. Ncgc00181037-03

75. Ncgc00258385-01

76. Ac-154802

77. Db-046999

78. Cs-0017450

79. Ft-0627416

80. C07518

81. D00545

82. P15338

83. A818554

84. Q413918

85. Sr-01000944965

86. Sr-01000944965-1

87. W-107162

88. 1-chloro-1-(difluoromethoxy)-2,2,2-trifluoroethane

89. 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane

90. 1-chloro-2,2,2-trifluroethyl Difluromethyl Ether

91. Ethane, 1-chloro-1-(difluoromethoxy)-2,2,2-trifluoro-

92. 2-[bis(fluoranyl)methoxy]-2-chloranyl-1,1,1-tris(fluoranyl)ethane

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 184.49 g/mol
Molecular Formula C3H2ClF5O
XLogP32.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass183.9714332 g/mol
Monoisotopic Mass183.9714332 g/mol
Topological Polar Surface Area9.2 Ų
Heavy Atom Count10
Formal Charge0
Complexity102
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameForane
Drug LabelFORANE (isoflurane, USP), a nonflammable liquid administered by vaporizing, is a general inhalation anesthetic drug. It is 1-chloro-2, 2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:Some physical constants are:Molecular weight...
Active IngredientIsoflurane
Dosage FormLiquid
RouteInhalation
Strength99.9%
Market StatusPrescription
CompanyBaxter Hlthcare

2 of 4  
Drug NameIsoflurane
Drug LabelIsoflurane, USP, is a nonflammable, nonexplosive general inhalation anesthetic agent. Its chemical name is 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:Each mL contains 99.9% Isoflurane.Some physical const...
Active IngredientIsoflurane
Dosage FormLiquid
RouteInhalation
Strength99.9%
Market StatusPrescription
CompanyHospira; Halocarbon Prods; Piramal Critical; Piramal Ent

3 of 4  
Drug NameForane
Drug LabelFORANE (isoflurane, USP), a nonflammable liquid administered by vaporizing, is a general inhalation anesthetic drug. It is 1-chloro-2, 2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:Some physical constants are:Molecular weight...
Active IngredientIsoflurane
Dosage FormLiquid
RouteInhalation
Strength99.9%
Market StatusPrescription
CompanyBaxter Hlthcare

4 of 4  
Drug NameIsoflurane
Drug LabelIsoflurane, USP, is a nonflammable, nonexplosive general inhalation anesthetic agent. Its chemical name is 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:Each mL contains 99.9% Isoflurane.Some physical const...
Active IngredientIsoflurane
Dosage FormLiquid
RouteInhalation
Strength99.9%
Market StatusPrescription
CompanyHospira; Halocarbon Prods; Piramal Critical; Piramal Ent

4.2 Therapeutic Uses

FORANE (isoflurane, USP) may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


In cases of life-threatening status asthmaticus which are refractory to drug therapy, the administration of inhalation anesthetics can be life-saving as they help alleviate bronchial spasm. We had an 11-year-old female patient suffering from status asthmaticus who was moribund from severe CO2 narcosis and was not responding to any of the conventional therapies. She finally fell into ventricular fibrillation. After cardiopulmonary resuscitation, we administered 2.0% isoflurane in oxygen. Within half an hour, her high inspiratory pressure was dramatically decreased, and then the isoflurane concentration was maintained at 1.0%. After 14 hours of isoflurane anesthesia, PaCO2 decreased to the normal level and the isoflurane treatment was discontinued. The endotracheal tube was removed 4 hours later. She had an uneventful recovery and was discharged from the hospital 11 days later. With its low metabolic rate and therefore low organ toxicity, as well as its low arrhythmogenicity with remarkable bronchodilating activity, we feel isoflurane may well be superior to other inhalation anesthetics in the treatment of status asthmaticus.

PMID:8433481 Shibata Y et al; Masui 42 (1): 116-9 (1993)


Vet: Isoflurane, USP is used for induction and maintenance of general anesthesia in horses and dogs.

US Natl Inst Health; DailyMed. Current Medication Information for Isoflurane USP (isoflurane) inhalant (August 2009). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0c8964f-24a8-4bab-ae8d-1536737e43ec


4.3 Drug Warning

Anesthetics, Inhalation

National Library of Medicine's Medical Subject Headings online file (MeSH, 2009) https://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?mode=&term=Isoflurane


In susceptible individuals, isoflurane anesthesia may trigger a skeletal muscle hypermetabolic state leading to high oxygen demand and the clinical syndrome known as malignant hyperthermia. The syndrome includes nonspecific features such as muscle rigidity, tachycardia, tachypnea, cyanosis, arrhythmias, and unstable blood pressure. (It should also be noted that many of these nonspecific signs may appear with light anesthesia, acute hypoxia, etc.) An increase in overall metabolism may be reflected in an elevated temperature, (which may rise rapidly early or late in the case, but usually is not the first sign of augmented metabolism) and an increased usage of the CO2 absorption system (hot canister). PaO2 and pH may decrease, and hyperkalemia and a base deficit may appear.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


Since levels of anesthesia may be altered easily and rapidly, only vaporizers producing predictable concentrations should be used. Hypotension and respiratory depression increase as anesthesia is deepened.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


Increased blood loss comparable to that seen with halothane has been observed in patients undergoing abortions.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


For more Drug Warnings (Complete) data for Isoflurane (24 total), please visit the HSDB record page.


4.4 Drug Indication

For induction and maintenance of general anesthesia.


FDA Label


Sedation of mechanically ventilated patients


5 Pharmacology and Biochemistry
5.1 Pharmacology

Isoflurane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.


5.2 MeSH Pharmacological Classification

Anesthetics, Inhalation

Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ISOFLURANE
5.3.2 FDA UNII
CYS9AKD70P
5.3.3 Pharmacological Classes
General Anesthetic [EPC]; General Anesthesia [PE]
5.4 ATC Code

N - Nervous system

N01 - Anesthetics

N01A - Anesthetics, general

N01AB - Halogenated hydrocarbons

N01AB06 - Isoflurane


5.5 Absorption, Distribution and Excretion

In the postanesthesia period, only 0.17% of the isoflurane taken up can be recovered as urinary metabolites.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


It is not known whether this drug is excreted in human milk.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


5.6 Metabolism/Metabolites

Minimal


Renal and hepatic toxicity of the fluorinated ether volatile anesthetics is caused by biotransformation to toxic metabolites. Metabolism also contributes significantly to the elimination pharmacokinetics of some volatile agents. Although innumerable studies have explored anesthetic metabolism in animals, there is little information on human volatile anesthetic metabolism with respect to comparative rates or the identity of the enzymes responsible for defluorination. The first purpose of this investigation was to compare the metabolism of the fluorinated ether anesthetics by human liver microsomes. The second purpose was to test the hypothesis that cytochrome P450 2E1 is the specific P450 isoform responsible for volatile anesthetic defluorination in humans. Microsomes were prepared from human livers. Anesthetic metabolism in microsomal incubations was measured by fluoride production. The strategy for evaluating the role of P450 2E1 in anesthetic defluorination involved three approaches: for a series of 12 human livers, correlation of microsomal defluorination rate with microsomal P450 2E1 content (measured by Western blot analysis), correlation of defluorination rate with microsomal P450 2E1 catalytic activity using marker substrates (para-nitrophenol hydroxylation and chlorzoxazone 6-hydroxylation), and chemical inhibition by P450 isoform-selective inhibitors. The rank order of anesthetic metabolism, assessed by fluoride production at saturating substrate concentrations, was methoxyflurane > sevoflurane > enflurane > isoflurane > desflurane > 0. There was a significant linear correlation of sevoflurane and methoxyflurane defluorination with antigenic P450 2E1 content (r = 0.98 and r = 0.72, respectively), but not with either P450 1A2 or P450 3A3/4. Comparison of anesthetic defluorination with either para-nitrophenol or chlorzoxazone hydroxylation showed a significant correlation for sevoflurane (r = 0.93, r = 0.95) and methoxyflurane (r = 0.78, r = 0.66). Sevoflurane defluorination was also highly correlated with that of enflurane (r = 0.93), which is known to be metabolized by human P450 2E1. Diethyldithiocarbamate, a selective inhibitor of P450 2E1, produced a concentration-dependent inhibition of sevoflurane, methoxyflurane, and isoflurane defluorination. No other isoform-selective inhibitor diminished the defluorination of sevoflurane, whereas methoxyflurane defluorination was inhibited by the selective P450 inhibitors furafylline (P450 1A2), sulfaphenazole (P450 2C9/10), and quinidine (P450 2D6) but to a much lesser extent than by diethyldithiocarbamate. These results demonstrate that cytochrome P450 2E1 is the principal, if not sole human liver microsomal enzyme catalyzing the defluorination of sevoflurane. P450 2E1 is the principal, but not exclusive enzyme responsible for the metabolism of methoxyflurane, which also appears to be catalyzed by P450s 1A2, 2C9/10, and 2D6. The data also suggest that P450 2E1 is responsible for a significant fraction of isoflurane metabolism. Identification of P450 2E1 as the major anesthetic metabolizing enzyme in humans provides a mechanistic understanding of clinical fluorinated ether anesthetic metabolism and toxicity.

PMID:8214760 Kharasch ED, Thummel KE; Anesthesiology 79 (4): 795-807 (1993)


Isoflurane undergoes minimal biotransformation in man.

US Natl Inst Health; DailyMed. Current Medication Information for Forane (isoflurane) inhalant (December 2011). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8


Renal and hepatic toxicity of the fluorinated ether volatile anesthetics is caused by biotransformation to toxic metabolites. Metabolism also contributes significantly to the elimination pharmacokinetics of some volatile agents. Although innumerable studies have explored anesthetic metabolism in animals, there is little information on human volatile anesthetic metabolism with respect to comparative rates or the identity of the enzymes responsible for defluorination. The first purpose of this investigation was to compare the metabolism of the fluorinated ether anesthetics by human liver microsomes. The second purpose was to test the hypothesis that cytochrome P450 2E1 is the specific P450 isoform responsible for volatile anesthetic defluorination in humans. Microsomes were prepared from human livers. Anesthetic metabolism in microsomal incubations was measured by fluoride production. The strategy for evaluating the role of P450 2E1 in anesthetic defluorination involved three approaches: for a series of 12 human livers, correlation of microsomal defluorination rate with microsomal P450 2E1 content (measured by Western blot analysis), correlation of defluorination rate with microsomal P450 2E1 catalytic activity using marker substrates (para-nitrophenol hydroxylation and chlorzoxazone 6-hydroxylation), and chemical inhibition by P450 isoform-selective inhibitors. The rank order of anesthetic metabolism, assessed by fluoride production at saturating substrate concentrations, was methoxyflurane > sevoflurane > enflurane > isoflurane > desflurane > 0. There was a significant linear correlation of sevoflurane and methoxyflurane defluorination with antigenic P450 2E1 content (r = 0.98 and r = 0.72, respectively), but not with either P450 1A2 or P450 3A3/4. Comparison of anesthetic defluorination with either para-nitrophenol or chlorzoxazone hydroxylation showed a significant correlation for sevoflurane (r = 0.93, r = 0.95) and methoxyflurane (r = 0.78, r = 0.66). Sevoflurane defluorination was also highly correlated with that of enflurane (r = 0.93), which is known to be metabolized by human P450 2E1. Diethyldithiocarbamate, a selective inhibitor of P450 2E1, produced a concentration-dependent inhibition of sevoflurane, methoxyflurane, and isoflurane defluorination. No other isoform-selective inhibitor diminished the defluorination of sevoflurane, whereas methoxyflurane defluorination was inhibited by the selective P450 inhibitors furafylline (P450 1A2), sulfaphenazole (P450 2C9/10), and quinidine (P450 2D6) but to a much lesser extent than by diethyldithiocarbamate. These results demonstrate that cytochrome P450 2E1 is the principal, if not sole human liver microsomal enzyme catalyzing the defluorination of sevoflurane. P450 2E1 is the principal, but not exclusive enzyme responsible for the metabolism of methoxyflurane, which also appears to be catalyzed by P450s 1A2, 2C9/10, and 2D6. The data also suggest that P450 2E1 is responsible for a significant fraction of isoflurane metabolism. Identification of P450 2E1 as the major anesthetic metabolizing enzyme in humans provides a mechanistic understanding of clinical fluorinated ether anesthetic metabolism and toxicity.

PMID:8214760 Kharasch ED, Thummel KE; Anesthesiology 79 (4): 795-807 (1993)


5.7 Mechanism of Action

Isoflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Isoflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. Also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Isoflurane also binds to the GABA receptor, the large conductance Ca2+ activated potassium channel, the glutamate receptor and the glycine receptor.


USDMF

read-more
read-moreread-more

01

Aesica Queenborough Ltd

United Kingdom

USDMF

arrow
APS Symposium
Not Confirmed

01

Aesica Queenborough Ltd

United Kingdom
arrow
APS Symposium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 9087

Submission : 1991-04-29

Status : Active

Type : II

blank

02

APS Symposium
Not Confirmed

02

APS Symposium
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-02-24

Pay. Date : 2021-01-11

DMF Number : 35361

Submission : 2020-12-22

Status : Active

Type : II

blank

04

Piramal Pharma Ltd

India

USDMF

arrow
APS Symposium
Not Confirmed

04

APS Symposium
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-01-30

Pay. Date : 2013-01-04

DMF Number : 9791

Submission : 1992-07-22

Status : Active

Type : II

blank

05

Great Lakes Chemical Corp

Country

USDMF

arrow
APS Symposium
Not Confirmed

05

Great Lakes Chemical Corp

Country
arrow
APS Symposium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 12045

Submission : 1996-07-15

Status : Inactive

Type : II

blank

06

Great Lakes Chemical Corp

Country

USDMF

arrow
APS Symposium
Not Confirmed

06

Great Lakes Chemical Corp

Country
arrow
APS Symposium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 10363

Submission : 1993-07-19

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652121000,"product":"ISOFLURANE","address":"304 AGGARWAL CITY SQUARE,MANGALAM","city":"DELHI,DELHI","supplier":"SHANDONG NEW TIME PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"SHEKOU","customer":"SHAH TC GLOBAL EXIM LLP","customerCountry":"INDIA","quantity":"5130.00","actualQuantity":"5130","unit":"KGS","unitRateFc":"33","totalValueFC":"168773.7","currency":"USD","unitRateINR":"2542.7","date":"10-May-2022","totalValueINR":"13043795","totalValueInUsd":"168773.7","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29420090","bill_no":"1008260","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHEKOU","supplierAddress":"NO.1 NORTH OUTER RING ROAD, FEIXIAN SHAND , CHINA CHINA","customerAddress":"304 AGGARWAL CITY SQUARE,MANGALAM"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658428200,"product":"ISOFLURANE IP\/USP","address":"304 AGGARWAL CITY SQUARE,MANGALAM","city":"DELHI,DELHI","supplier":"SHANDONG NEW TIME PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"SHEKOU","customer":"SHAH TC GLOBAL EXIM LLP","customerCountry":"INDIA","quantity":"5130.00","actualQuantity":"5130","unit":"KGS","unitRateFc":"33","totalValueFC":"172341.8","currency":"USD","unitRateINR":"2671.4","date":"22-Jul-2022","totalValueINR":"13704026","totalValueInUsd":"172341.8","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29420090","bill_no":"1013040","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHEKOU","supplierAddress":"NO.1 NORTH OUTER RING ROAD, FEIXIAN SHAND , CHINA CHINA","customerAddress":"304 AGGARWAL CITY SQUARE,MANGALAM"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673548200,"product":"ISOFLURANE, USP (BATCH NO. 806-2109002M MFG.DT15.10.2021 EXP DT.14.10.2026)","address":"B-106, TECHNO CITY, X 4\/1,,TTC IND USTRIAL AREA, MIDC, MAHAPE,","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"FUJIAN HIGHSEA UNITED PHARMACEUTICA","supplierCountry":"CHINA","foreign_port":"NA","customer":"LAVINIA LIFE SCIENCES PRIVATE LIMITED","customerCountry":"INDIA","quantity":"1500.00","actualQuantity":"1500","unit":"KGS","unitRateFc":"30.5","totalValueFC":"46751.9","currency":"USD","unitRateINR":"2548.3","date":"13-Jan-2023","totalValueINR":"3822412.5","totalValueInUsd":"46751.9","indian_port":"JNPT","hs_no":"29091990","bill_no":"4165826","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"B-106, TECHNO CITY, X 4\/1,,TTC IND USTRIAL AREA, MIDC, MAHAPE,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677868200,"product":"ISOFLURANE IP\/USP","address":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES","city":"BUNGALOW RD BODAKDEV AHMEDABAD,GUJA","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"NA","customer":"TROIKAA PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"4086.85","actualQuantity":"4086.85","unit":"KGS","unitRateFc":"36","totalValueFC":"149361.9","currency":"USD","unitRateINR":"3006","date":"04-Mar-2023","totalValueINR":"12285071.1","totalValueInUsd":"149361.9","indian_port":"JNPT","hs_no":"29420090","bill_no":"4905692","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684175400,"product":"FOC-ISOFLURANE","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"","supplier":"BAXTER HEALTHCARE OF PUERTO RICO","supplierCountry":"UNITED STATES","foreign_port":"N\/A","customer":"SYNGENE INTERNATIONAL LIMITED UNIT V","customerCountry":"INDIA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"43.3","totalValueFC":"173.9","currency":"USD","unitRateINR":"3578.3","date":"16-May-2023","totalValueINR":"14313","totalValueInUsd":"173.9","indian_port":"Biocon-SEZ","hs_no":"29095090","bill_no":"1006637","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"530 ROAD # 5 PALMAS BUILDING # 1 CATANO , PUERTO RICO PR 00962","customerAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685730600,"product":"ISOFLURANE IP\/USP","address":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES","city":"BUNGALOW RD BODAKDEV AHMEDABAD,GUJA","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"NA","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"4320.00","actualQuantity":"4320","unit":"KGS","unitRateFc":"36","totalValueFC":"157797.5","currency":"USD","unitRateINR":"3002.1","date":"03-Jun-2023","totalValueINR":"12970368.11","totalValueInUsd":"157797.5","indian_port":"JNPT","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688409000,"product":"ISOFLURANE IP\/USP","address":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES","city":"BUNGALOW RD BODAKDEV AHMEDABAD,GUJA","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"NA","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"4590.00","actualQuantity":"4590","unit":"KGS","unitRateFc":"36","totalValueFC":"166970","currency":"USD","unitRateINR":"2989.6","date":"04-Jul-2023","totalValueINR":"13723181.86","totalValueInUsd":"166970","indian_port":"JNPT","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GF-1,GROUND FLOOR,COMMERCE HOUSE 1 ,,OPP.RAJVANSH APPT,JUDGES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697913000,"product":"ISOFLURANE IP\/USP","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"11610.00","actualQuantity":"11610","unit":"KGS","unitRateFc":"36","totalValueFC":"422834.7","currency":"USD","unitRateINR":"3031.2","date":"22-Oct-2023","totalValueINR":"35192232","totalValueInUsd":"422834.7","indian_port":"JNPT","hs_no":"29420090","bill_no":"8427107","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER, 61 MODY ROAD, TSIM SHA TSUI,KOWLOONSDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700677800,"product":"ISOFLURANE IP\/USP","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"2196.10","actualQuantity":"2196.1","unit":"KGS","unitRateFc":"36","totalValueFC":"79846.8","currency":"USD","unitRateINR":"3027.6","date":"23-Nov-2023","totalValueINR":"6648912.36","totalValueInUsd":"79846.8","indian_port":"JNPT","hs_no":"29420090","bill_no":"8901108","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER,61 MODY ROAD, TSIM SHA TSUI,KOWLOONSDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700677800,"product":"ISOFLURANE IP\/USP","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"2663.90","actualQuantity":"2663.9","unit":"KGS","unitRateFc":"36","totalValueFC":"96855.3","currency":"USD","unitRateINR":"3027.6","date":"23-Nov-2023","totalValueINR":"8065223.64","totalValueInUsd":"96855.3","indian_port":"JNPT","hs_no":"29420090","bill_no":"8901108","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER,61 MODY ROAD, TSIM SHA TSUI,KOWLOONSDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702233000,"product":"ISOFLURANE IP\/USP(12DRUM)(IUPAC NAME -2-CHLORO-2-(DIFLUOROMETHOXY)-1,1,1-TRIFLUOROETHANE)(CAS NO. 26675-46-7)","address":"301 CEEJAY HOUSE LEVEL 3 SHIVSAGAR","city":"MUMBAI,MAHARASHTRA","supplier":"XXANDXXG GXXKGOXXNTEXXATIXXAL XXADIXX COXXLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"ARSHIYA LOGISTICS SERVICES LTD","customerCountry":"INDIA","quantity":"3240.00","actualQuantity":"3240","unit":"KGS","unitRateFc":"31.9","totalValueFC":"104504.1","currency":"USD","unitRateINR":"2685","date":"11-Dec-2023","totalValueINR":"8699254","totalValueInUsd":"104504.1","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29420090","bill_no":"1021558","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"N\/A","customerAddress":"301 CEEJAY HOUSE LEVEL 3 SHIVSAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711650600,"product":"ISOFLURANE IP\/USP","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"QINGDAO","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"270.00","actualQuantity":"270","unit":"KGS","unitRateFc":"36","totalValueFC":"9832.9","currency":"USD","unitRateINR":"3024","date":"29-Mar-2024","totalValueINR":"816480","totalValueInUsd":"9832.9","indian_port":"JNPT","hs_no":"29420090","bill_no":"2799243","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"QINGDAO","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER, 61 MODY ROAD, TSIM SHA TSUI,KOWLOONSDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721068200,"product":"ISOFLURANE IP\/USP - BATCH NO.597240403","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"4050.00","actualQuantity":"4050","unit":"KGS","unitRateFc":"36","totalValueFC":"147298.1","currency":"USD","unitRateINR":"3040.2","date":"16-Jul-2024","totalValueINR":"12312810","totalValueInUsd":"147298.1","indian_port":"JNPT","hs_no":"29420090","bill_no":"4539677","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER, 61 MODY ROAD, TSIM SHA TSUI,KOWLOONSDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729794600,"product":"ISOFLURANE USP (4997 BOTTLES X 250ML\/1000 = 1249.250 LITER EQUIVALENT TO 1868.878 KGS)","address":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE","city":"BUNGALOW ROAD, BODAKDEV AHMEDABAD.","supplier":"LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED","supplierCountry":"CHINA","foreign_port":"QINGDAO","customer":"TROIKAA PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"1868.00","actualQuantity":"1868","unit":"KGS","unitRateFc":"35","totalValueFC":"66098.5","currency":"USD","unitRateINR":"2973.3","date":"25-Oct-2024","totalValueINR":"5554031","totalValueInUsd":"66098.5","indian_port":"JNPT","hs_no":"29420090","bill_no":"6327364","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"QINGDAO","supplierAddress":"UNIT 2 OF LG 1, MIRROR TOWER, 61 MO DY ROAD, TSIM SHA TSUI KOWLOON SDNF Hong Kong","customerAddress":"GF- 1 , GROUND FLOOR,COMMERCE HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730053800,"product":"ISOFLURANE IP\/USP (LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED) IUPAC NAME : 2-CHLORO-2-(DIFLUOROMETHOXY)-1,1,1-TRIFLISOFLURANE IP\/USP (LONGCHEM INTERNATIONAL TRADING COMPANY LI","address":"DARABSHAW HOUSE LEVEL 1 SHOORJI","city":"MUMBAI","supplier":"SHANDONG NEW TIME PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"NHAVA SHEVA BUSINESS PARK PRIVATE LIMITED","customerCountry":"INDIA","quantity":"4050.00","actualQuantity":"4050","unit":"KGS","unitRateFc":"31.9","totalValueFC":"130410.1","currency":"USD","unitRateINR":"2705.7","date":"28-Oct-2024","totalValueINR":"10957912.88","totalValueInUsd":"130410.1","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29420090","bill_no":"6378710","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.1, NORTH OUTER RING ROAD, FEIXIA N COUNTY, SHANDONG, CHINA Shandong, , CHINA CHINA","customerAddress":"DARABSHAW HOUSE LEVEL 1 SHOORJI"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731868200,"product":"ISOFLURANE IP\/USP (20DRM) IUPAC NAME : 2-CHLORO-2-(DIFLUOROMETHOXY)-1,1,1-TRIFLUOROETHANE(29420090)RAW MATERIALISOFLURANE IP\/USP (20DRM) IUPAC NAME : 2-CHLORO-2-(DIFLEOROM","address":"305 AGGARWAL CITY SQUARE","city":"DELHI","supplier":"SHAH TC GLOBAL EXIM LLP","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"SHAH TC DISTRIBUTION LLP","customerCountry":"INDIA","quantity":"5400.00","actualQuantity":"5400","unit":"KGS","unitRateFc":"32","totalValueFC":"174667.1","currency":"USD","unitRateINR":"2729.6","date":"18-Nov-2024","totalValueINR":"14739840","totalValueInUsd":"174667.1","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29420090","bill_no":"6730081","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UNIT NO. 142, 1ST FLOOR, ADMINISTRA TIVE BUILDING, , ARSHIYA FTWZ VILLA GE SAI TALUKA PANVEL,MAHARASHTRA, N INDIA","customerAddress":"305 AGGARWAL CITY SQUARE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739989800,"product":"ISOFLURANE [FORM-11 LIC. NO. SW\/OD\/11\/2024\/000008444 DT.24\/12\/2025]ISOFLURANE [TEST LIC. SW\/OD\/11\/2024\/000008444 DT.24\/12\/2025]","address":"207\/208,UDYOG BHAVAN,SONAWALA ROAD,","city":"MUMBAI ,MAHARASHTRA","supplier":"ZHUHAI YIPIN PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"SUPRIYA LIFESCIENCE LIMITED","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"33.5","totalValueFC":"851.3","currency":"USD","unitRateINR":"2961.4","date":"20-Feb-2025","totalValueINR":"74035","totalValueInUsd":"851.3","indian_port":"JNPT","hs_no":"29091990","bill_no":"8471631","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.706F, ZHUHAI INTERNATIONAL TECHN OLOGY BUILDING NO.288 HONGSHAN ROAD , XIANGZHOU DISTRICT, ZHUHAI, CHINA CHINA","customerAddress":"207\/208,UDYOG BHAVAN,SONAWALA ROAD,"}]
10-May-2022
20-Feb-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

AbbVie Inc

U.S.A

isoflurane

Brand Name : Forene

Dosage Form : INHALATION VAPOR, LIQUID

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Abbvie Company Banner

02

AbbVie Inc

U.S.A

Isoflurane

Brand Name : Unify

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Bottle of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Abbvie Company Banner

03

AbbVie Inc

U.S.A

Isoflurane

Brand Name : Forane

Dosage Form : INF

Dosage Strength : 250ml

Packaging : 100X1ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Isoflurane

Brand Name :

Dosage Form : Inhaler solution

Dosage Strength : 250ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Isoflurane

Brand Name :

Dosage Form : Inhaler solution

Dosage Strength : 100ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Isoflurane

Brand Name :

Dosage Form : Inhaler solution

Dosage Strength : 50ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

07

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

ISOFLURANE

Brand Name : AERRANE

Dosage Form : LIQUID

Dosage Strength : 100%

Packaging : 100ML/250ML

Approval Date :

Application Number : 2225875

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Bayer AG

Germany
DIA 2025
Not Confirmed
arrow

Bayer AG

Germany
arrow
DIA 2025
Not Confirmed

Isoflurane

Brand Name : Isoflurane Baxter

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Container of dark glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Hana Pharm

South Korea
DIA 2025
Not Confirmed
arrow

Hana Pharm

South Korea
arrow
DIA 2025
Not Confirmed

Isoflurane

Brand Name : IfranSolution

Dosage Form : SOLUTION

Dosage Strength : 100ML

Packaging : 100mL/BTL

Approval Date :

Application Number : 75225

Regulatory Info : Generic

Registration Country : South Korea

blank

10

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

ISOFLURANE

Brand Name : ISOFLURANE

Dosage Form : LIQUID;INHALATION

Dosage Strength : 99.9%

Packaging :

Approval Date : 1993-01-25

Application Number : 74097

Regulatory Info : DISCN

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

AbbVie Inc

U.S.A

isoflurane

Brand Name : Forene

Dosage Form : INHALATION VAPOR, LIQUID

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Abbvie Company Banner

02

AbbVie

U.S.A

Isoflurane

Brand Name : Unify

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Bottle of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Abbvie Company Banner

03

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

isoflurane

Brand Name : Isoflurane Baxter

Dosage Form : INHALATION VAPOR, LIQUID

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

BAXTER SpA

Germany
APS Symposium
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
APS Symposium
Not Confirmed

Isoflurane

Brand Name : Aerrane

Dosage Form : Isoflurane 100Ml Inhalation Use

Dosage Strength : inhal 100 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

BAXTER SpA

Germany
DIA 2025
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
DIA 2025
Not Confirmed

Isoflurane

Brand Name : Aerrane

Dosage Form : Isoflurane 250Ml Inhalation Use

Dosage Strength : inhal 250 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

BAXTER SpA

Germany
APS Symposium
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
APS Symposium
Not Confirmed

Isoflurane

Brand Name : Aerrane

Dosage Form : Isoflurane 100Ml 6 Units Inhalation Use

Dosage Strength : 6 bottles inhal 100 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

BAXTER SpA

Germany
DIA 2025
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
DIA 2025
Not Confirmed

Isoflurane

Brand Name : Aerrane

Dosage Form : Isoflurane 250Ml 6 Units Inhalation Use

Dosage Strength : 6 bottles inhal 250 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Baxter AS

Germany
APS Symposium
Not Confirmed
arrow

Baxter AS

Germany
arrow
APS Symposium
Not Confirmed

Isoflurane

Brand Name : Isoflurane Baxter

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Container of dark glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Baxter AS

Germany
DIA 2025
Not Confirmed
arrow

Baxter AS

Germany
arrow
DIA 2025
Not Confirmed

Isoflurane

Brand Name : Isoflurane Baxter

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Container of dark glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

Baxter AS

Germany
APS Symposium
Not Confirmed
arrow

Baxter AS

Germany
arrow
APS Symposium
Not Confirmed

Isoflurane

Brand Name : Isoflurane Baxter

Dosage Form : Fluid to inhalasjonsdamp

Dosage Strength :

Packaging : Container of dark glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

read-more
read-more
A consulting company based out of Portugal is looking for Europen/FDA/WHO GMP suppliers of various finished formulations. 39. Etomidate 2mg/ml Injection (10ml)- 5,000 Ampoules 40. Isoflurane (B/250ml)- 3,000 vials 41. Lignocaine HCl 2% (V/50ml)- 20,000 42. Midazolam HCl 1mg/ml (Amp/5ml)- 42,000 Ampoule 43. Phenylephrine 10mg/ml- 3,000 Ampoule 44. Propofol Injection 10mg/mL Vial/20ml- 2,000 vials 45. Suxamethonium Chloride 50mg/ml - 30,000 46. Sevoflurane Gas (250ml)- 3,000 units 47. Vecuronium10mg/ml injection- 2,000 Ampoule 48. Sodium Bicarbonate 8.5% injection- 10,000 49. Neostigmine 2.5mg/ml-10,000 Ampoules 50. Morphine injection- 100,000 Ampoules 51. Morphine tablets 10mg- 20,000 units 52. Pethidine 50mg/ml inj- 360,000 Ampoule 53. Indomethacin suppositories- 15,000 54. Benzhexol 5mg tablets- 10,000 units 55. Carbamazepine 200mg tablets- 50,000 units 56. Chlorpromazine 25mg tablets- 15,000 units 57. Chlorpromazine 100mg tablets- 15,000 units 58. Diazepam 5mg tablets- 7,000 units 59. Chlorpromazine injection- 80,000 Ampoules 60. Diazepam injection- 80,000 Ampoules 61. Fluphenazine deconoate injections- 100,000 Ampoule 62. Risperidone 1mg tablets- 6,000 units 63. Sulpiride 200mg tablets- 6,000 units 64. Trifluoperazine 5mg tablets- 5,000 units 65. Haloperidol 500mg tablets- 6,000 units 66. Haloperidol injection- 2,000 Ampoules 67. Lamotrigine 25mg tablets- 5000 units 68. Clonazepam 1mg tablets- 3,000 units 69. Sodium Valproate 200mg tablets- 3000 units 70. Phenytoin 100mg tablets- 8,000 units 71. Phenytoin injection- 3,000 Ampoules 72. Amitriptyline 25mg tablets- 8,000 units 73. Fluoxetine 20mg tablets- 8,000 units
06 Jan 2020

Reply

06 Jan 2020

Reply text-arrow

Reply Comment (14)

06 Jan 2020

Kab Orgo Chem is an International indenting agency strategically located in Mumbai, India. The company is looking for the suppliers of the following dosage forms: 1) Amoxicillin Capsule- 500 mg/ Quantity- 18,50,000 units 2) Calcium Pantothenate Tablets- 100mg/ Quantity- 12,00,000 units 3) Amphotericin B- Liposomal Injection, Powder for solution- 50mg 4) Amphotericin B- Injection, Powder for solution- 50mg 5) Atracurium Besylate Injection- 10mg/ml, 10mg/2.5 ml, 10mg/ 5ml 6) Bleomycin Injection, Powder for Solution- 15 (IU) 7) Brentuximab Injection- 50mg 8) Busulfan Injection- 6mg/ ml, 6mg/ 10ml 9) Cefotaxime Injection, Powder for Solution- 500mg 10) Ceftizoxime Injection, Powder for Solution- 1g 11) Chlormethine Injection- 10mg 12) Cisatracurium Injection- 2mg/ml, 2mg/5ml 13) Cromolyn Sodium Capsule- 20mg 14) Dicyclomine Hydrochloride- 10mg/ 5ml, 10mg/ 60ml 15) Erythromycin Tablet- 400mg 16) Estradiol Valerate Injection- 10mg/ml 17) Ethosuximide Capsule- 250mg 18) Fluconazole Capsule- 150mg/ 50mg 19) Fluconazole Tablet- 100mg 20) Haemodialysis Acidic Solution- 3710meq/35 meq/87.5 me/1L 4920 mL 21) Iopromide Injection- 300mg/ml, 300mg/100ml, 300mg/ 20ml, 300mg/ 50ml 22) Isoflurane Inhalant Respiratory- 100ml 23) Lithium Carbonate Tablet- 300mg 24) Melphalan 50mg Vial 25) Mycophenolate Mofetil Capsule- 250mg 26) Nortriptyline Tablets- 10mg/25mg 27) Nystatin Powder, For Suspension 100000 [IU]/1ml 28) Nystatin Tablet 500000 [IU] 29) Peritoneal Dialysis I Solution- 13.62 G/132 Meq/3.5 Meq/1.5 Me/1000ml 30) Peritoneal Dialysis II Solution- 22.7 G/1025.67 Meq/3.5 Meq/1.5/1000 Ml 31) Peritoneal Dialysis III Solution- 38.6g/5.67g/0.257g/0.152g//1000ml 32) Potassium Chloride 15% 50ml Vial 33) Propofol 2% Vial 50ml 34) Selegiline Hydrochloride Tablet- 5mg 35) Succinylcholine Chloride Injection- 50mg/1ml 10ml 36) Valproate Sodium Syrup 300mg/5ml 250ml 37) Valproate Sodium Tablet 38) Valsartan Tablet- 80mg 39) Vitamin B2 Tablet
11 Aug 2018

Reply

11 Aug 2018

Reply text-arrow

Reply Comment (0)

11 Aug 2018

PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 26675-46-7 / Isoflurane API manufacturers, exporters & distributors?

Isoflurane manufacturers, exporters & distributors 1

54

PharmaCompass offers a list of Isoflurane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isoflurane manufacturer or Isoflurane supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isoflurane manufacturer or Isoflurane supplier.

PharmaCompass also assists you with knowing the Isoflurane API Price utilized in the formulation of products. Isoflurane API Price is not always fixed or binding as the Isoflurane Price is obtained through a variety of data sources. The Isoflurane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Isoflurane

Synonyms

26675-46-7, Forane, 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane, Forene, Aerrane

Cas Number

26675-46-7

Unique Ingredient Identifier (UNII)

CYS9AKD70P

About Isoflurane

A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Forene Manufacturers

A Forene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Forene, including repackagers and relabelers. The FDA regulates Forene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Forene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Forene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Forene Suppliers

A Forene supplier is an individual or a company that provides Forene active pharmaceutical ingredient (API) or Forene finished formulations upon request. The Forene suppliers may include Forene API manufacturers, exporters, distributors and traders.

click here to find a list of Forene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Forene USDMF

A Forene DMF (Drug Master File) is a document detailing the whole manufacturing process of Forene active pharmaceutical ingredient (API) in detail. Different forms of Forene DMFs exist exist since differing nations have different regulations, such as Forene USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Forene DMF submitted to regulatory agencies in the US is known as a USDMF. Forene USDMF includes data on Forene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Forene USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Forene suppliers with USDMF on PharmaCompass.

Forene CEP

A Forene CEP of the European Pharmacopoeia monograph is often referred to as a Forene Certificate of Suitability (COS). The purpose of a Forene CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Forene EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Forene to their clients by showing that a Forene CEP has been issued for it. The manufacturer submits a Forene CEP (COS) as part of the market authorization procedure, and it takes on the role of a Forene CEP holder for the record. Additionally, the data presented in the Forene CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Forene DMF.

A Forene CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Forene CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Forene suppliers with CEP (COS) on PharmaCompass.

Forene WC

A Forene written confirmation (Forene WC) is an official document issued by a regulatory agency to a Forene manufacturer, verifying that the manufacturing facility of a Forene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Forene APIs or Forene finished pharmaceutical products to another nation, regulatory agencies frequently require a Forene WC (written confirmation) as part of the regulatory process.

click here to find a list of Forene suppliers with Written Confirmation (WC) on PharmaCompass.

Forene GMP

Forene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Forene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Forene GMP manufacturer or Forene GMP API supplier for your needs.

Forene CoA

A Forene CoA (Certificate of Analysis) is a formal document that attests to Forene's compliance with Forene specifications and serves as a tool for batch-level quality control.

Forene CoA mostly includes findings from lab analyses of a specific batch. For each Forene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Forene may be tested according to a variety of international standards, such as European Pharmacopoeia (Forene EP), Forene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Forene USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty